Bristol Meyers Squibb Update | BMY
On October 20. In 2025, we suggest people take an aggressive bullish position on Bristol-Myers Squibb by purchasing a long-dated bullish risk reversal. This article is for registered members -…
On October 20. In 2025, we suggest people take an aggressive bullish position on Bristol-Myers Squibb by purchasing a long-dated bullish risk reversal. This article is for registered members -…
Today, we would like to discuss an ignored and disliked company, Bristol-Myers Squibb. This article is for paid members - please login or subscribe for access.
Bristol Meyers Squib is an ethical pharmaceutical company that makes many of the products we use when we get sick. This article is for paid members - please login or…
The healthcare sector is largely recession-resistant, and its products are typically patent-protected, reducing or eliminating competition. Competition typically comes from another patent-protected product that treats the same disease. This article…
Standard Monthly Options will be expiring at the end of the week, so we thought we should highlight the trades that are due to expire. This article is for registered…
The equity markets seem to be overreacting to politics. The trade dustup is front and center and every news item sends prices flying or crashing. The tech companies that have…